2022. THE IMPACT OF TERLIPRESSIN ON HEPATORENEAL DISEASE: RESULTS OF AN OBSERVATIONAL, DESCRIPTIVE, AND CROSS-SECTIONAL STUDY DISEASE. Journal of Pharmaceutical Negative Results. (Dec. 2022), 2320–2326.